Abstract
NA
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 143-144 |
| Numero di pagine | 2 |
| Rivista | Cardiovascular Drugs and Therapy |
| Volume | 34 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2020 |
Keywords
- Anticoagulants
- Atrial Fibrillation
- Clinical Decision-Making
- Coronary Artery Disease
- Drug Therapy, Combination
- Drug Utilization
- Dual Anti-Platelet Therapy
- Fibrinolytic Agents
- Hemorrhage
- Humans
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors
- Practice Patterns, Physicians'
- Risk Factors
- Treatment Outcome
Fingerprint
Entra nei temi di ricerca di 'From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver